Crosslinked chitosan implants as potential degradable devices for brachytherapy: In vitro and in vivo analysis

Journal of Controlled Release

Volumn 111, Issue 3, 2006, Pages 281-289

  Azab, Abdel Kareem ^a   Orkin, Boris ^a,b   Doviner, Victoria ^b   Nissan, Aviram ^b   Klein, Martine ^b   Srebnik, Morris ^a   Rubinstein, Abraham ^a  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^b HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

131I norcholesterol; Brachytherapy; Chitosan; Degradable implant; In vivo degradation

Indexed keywords

BIOMEDICAL ENGINEERING; DEGRADATION; DIALYSIS; GROWTH KINETICS; HYDRATION; HYDROGELS; RADIATION EFFECTS; THERMAL EFFECTS;

131I-NORCHOLESTEROL; BRACHYTHERAPY; DEGRADABLE IMPLANTS; IN VIVO DEGRADATION;

DRUG THERAPY;

CHITOSAN; GLUTARALDEHYDE; NORCHOLESTEROL I 131; RADIOACTIVE MATERIAL; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; BIODEGRADABLE IMPLANT; BRACHYTHERAPY; CROSS LINKING; DEGRADATION KINETICS; DEVICE; DRUG DEGRADATION; DRUG IMPLANT; DRUG RELEASE; HYDRATION; HYDROGEL; IN VITRO STUDY; IN VIVO STUDY; NONHUMAN; PRIORITY JOURNAL; RAT;

19-IODOCHOLESTEROL; ANIMALS; BIOCOMPATIBLE MATERIALS; BRACHYTHERAPY; CHITOSAN; CROSS-LINKING REAGENTS; DRUG IMPLANTS; GLUTARAL; HYDROGELS; IODINE RADIOISOTOPES; RATS;

EID: 33645302350     PISSN: 01683659     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jconrel.2005.12.014     Document Type: Article

References (40)

1. M. Abeloff, J. Armitage, J. Niederhuber, M. Kastan, and M.W.G. Clinical Oncology 2004 Elsevier
2. L.E. Gaspar Brachytherapy in lung cancer J. Surg. Oncol. 67 1998 60 70
3. G.K. Edmundson, F.A. Vicini, P.Y. Chen, C. Mitchell, and A.A. Martinez Dosimetric characteristics of the MammoSite RTS, a new breast brachytherapy applicator Int. J. Radiat. Oncol. Biol. Phys. 52 2002 1132 1139
4. L.A. DiFronzo, P.I. Tsai, J.M. Hwang, J.J. Lee, M.C. Ryoo, J. Rahimian, M. Tome, J.K. Takasugi, and P.I. Haigh Breast conserving surgery and accelerated partial breast irradiation using the MammoSite system: initial clinical experience Arch. Surg. 140 2005 787 794
5. S. Nag, B. Erickson, B. Thomadsen, C. Orton, J.D. Demanes, and D. Petereit The American Brachytherapy Society recommendations for high-dose-rate brachytherapy for carcinoma of the cervix Int. J. Radiat. Oncol. Biol. Phys. 48 2000 201 211
6. S. Nag, W. Bice, K. DeWyngaert, B. Prestidge, R. Stock, and Y. Yu The American Brachytherapy Society recommendations for permanent prostate brachytherapy postimplant dosimetric analysis Int. J. Radiat. Oncol. Biol. Phys. 46 2000 221 230
7. 192Ir sources used in interstitial brachytherapy Appl. Radiat. Isotopes 55 2001 189 195
8. D.R. Holmes III, B.J. Davis, C.J. Bruce, and R.A. Robb 3D visualization, analysis, and treatment of the prostate using trans-urethral ultrasound Comput. Med. Imaging Graph 27 2003 339 349
9. B.J. Davis, D.H. Brinkmann, J.J. Kruse, M.G. Herman, W.N. LaJoie, D.J. Schwartz, T.M. Pisansky, and R.W. Kline Selective identification of different brachytherapy sources, ferromagnetic seeds, and fiducials in the prostate using an automated seed sorting algorithm Brachytherapy 3 2004 106 112
10. J.L. Wright, J.H. Newhouse, J.L. Laguna, D. Vecchio, and R.D. Ennis Localization of neurovascular bundles on pelvic CT and evaluation of radiation dose to structures putatively involved in erectile dysfunction after prostate brachytherapy Int. J. Radiat. Oncol. Biol. Phys. 59 2004 426 435
11. V.J. Zannis, L.C. Walker, B. Barclay-White, and C.A. Quiet Postoperative ultrasound-guided percutaneous placement of a new breast brachytherapy balloon catheter Am. J. Surg. 186 2003 383 385
12. F. Perera, F. Chisela, J. Engel, and V. Venkatesan Method of localization and implantation of the lumpectomy site for high dose rate brachytherapy after conservative surgery for T1 and T2 breast cancer Int. J. Radiat. Oncol. Biol. Phys. 31 1995 959 965
13. A.F. Sedda, M. Adamo, G. Rossi, C. Cipriani, Composition containing radioisotopes immobilized on solid particles and its use in brachytherapy, Eur. Patent EP0979656 (2000).
14. E.J. Kaplan, Method of administering a therapeutically active substance, U.S. Patent 6,514,193 (2003).
15. M.N. Kumar, R.A. Muzzarelli, C. Muzzarelli, H. Sashiwa, and A.J. Domb Chitosan chemistry and pharmaceutical perspectives Chem. Rev. 104 2004 6017 6084
16. A. Yokoyama, S. Yamamoto, T. Kawasaki, T. Kohgo, and M. Nakasu Development of calcium phosphate cement using chitosan and citric acid for bone substitute materials Biomaterials 23 2002 1091 1101
17. J. Ma, H. Wang, B. He, and J. Chen A preliminary in vitro study on the fabrication and tissue engineering applications of a novel chitosan bilayer material as a scaffold of human neofetal dermal fibroblasts Biomaterials 22 2001 331 336
18. H. Ueno, H. Yamada, I. Tanaka, N. Kaba, M. Matsuura, M. Okumura, T. Kadosawa, and T. Fujinaga Accelerating effects of chitosan for healing at early phase of experimental open wound in dogs Biomaterials 20 1999 1407 1414
19. F.L. Mi, Y.C. Tan, H.F. Liang, and H.W. Sung In vivo biocompatibility and degradability of a novel injectable-chitosan-based implant Biomaterials 23 2002 181 191
20. J. Berger, M. Reist, J.M. Mayer, O. Felt, and R. Gurny Structure and interactions in chitosan hydrogels formed by complexation or aggregation for biomedical applications Eur. J. Pharm. Biopharm. 57 2004 35 52
21. J. Berger, M. Reist, J.M. Mayer, O. Felt, N.A. Peppas, and R. Gurny Structure and interactions in covalently and ionically crosslinked chitosan hydrogels for biomedical applications Eur. J. Pharm. Biopharm. 57 2004 19 34
22. V. Crescenzi, A. Francescangeli, A. Taglienti, D. Capitani, and L. Mannina Synthesis and partial characterization of hydrogels obtained via glutaraldehyde crosslinking of acetylated chitosan and of hyaluronan derivatives Biomacromolecules 4 2003 1045 1054
23. S.A. Agnihotri, N.N. Mallikarjuna, and T.M. Aminabhavi Recent advances on chitosan-based micro- and nanoparticles in drug delivery J. Control. Release 100 2004 5 28
24. E. Khor, and L.Y. Lim Implantable applications of chitin and chitosan Biomaterials 24 2003 2339 2349
25. I. Gliko-Kabir, B. Yagen, A. Penhasi, and A. Rubinstein Low swelling, crosslinked guar and its potential use as colon-specific drug carrier Pharm. Res. 15 1998 1019 1025
26. I. Gliko-Kabir, B. Yagen, A. Penhasi, and A. Rubinstein Phosphated crosslinked guar for colon-specific drug delivery. I. Preparation and physicochemical characterization J. Control. Release 63 2000 121 127
27. M.H. Ross, G.I. Kaye, and W. Pawlina Histology: a Text and Atlas 2003 Lippincott Williams and Wilkins Philadelphia
28. A. Bigi, G. Cojazzi, S. Panzavolta, N. Roveri, and K. Rubini Stabilization of gelatin films by crosslinking with genipin Biomaterials 23 2002 4827 4832
29. K.S. Anseth, A.T. Metters, S.J. Bryant, P.J. Martens, J.H. Elisseeff, and C.N. Bowman In situ forming degradable networks and their application in tissue engineering and drug delivery J. Control. Release 78 2002 199 209
30. N.J. Einerson, K.R. Stevens, and W.J. Kao Synthesis and physicochemical analysis of gelatin-based hydrogels for drug carrier matrices Biomaterials 24 2003 509 523
31. A.W. Adamson A Textbook of Physical Chemistry 1973 Academic Press Inc. New York
32. C.S. Spyropoulos Cytoplasmic gel and water relations of axon J. Membr. Biol. 47 1979 195 238
33. M.E. Aulton Pharmaceutics: the Science of Dosage Form Design 2001 Churchill Livingstone New York
34. D.L. French, B.O. Haglund, K.J. Himmelstein, and J.W. Mauger Controlled release of substituted benzoic and naphthoic acids using Carbopol gels: measurement of drug concentration profiles and correlation to release rate kinetics Pharm. Res. 12 1995 1513 1520
35. T. Ehrenfreund-Kleinman, Z. Gazit, D. Gazit, T. Azzam, J. Golenser, and A.J. Domb Synthesis and biodegradation of arabinogalactan sponges prepared by reductive amination Biomaterials 23 2002 4621 4631
36. T. Yasukawa, H. Kimura, N. Kunou, H. Miyamoto, Y. Honda, Y. Ogura, and Y. Ikada Biodegradable scleral implant for intravitreal controlled release of ganciclovir Graefe Arch. Clin. Exp. Ophthalmol. 238 2000 186 190
37. K.W. Leong, B.C. Brott, and R. Langer Bioerodible polyanhydrides as drug-carrier matrices. I. Characterization, degradation, and release characteristics J. Biomed. Mater. Res. 19 1985 941 955
38. D.T. Yapp, D.K. Lloyd, J. Zhu, and S. Lehnert Radiosensitization of a mouse tumor model by sustained intra-tumoral release of etanidazole and tirapazamine using a biodegradable polymer implant device Radiother. Oncol. 53 1999 77 84
39. M. Laval-Jeantet, A.M. Laval-Jeantet, and O. Bacques Experimental opacification of mediastinal lymph nodes by intraperitoneal injection of an iodinated fatty emulsion Lymphology 12 1979 101 107
40. S. Levine Postinflammatory increase of absorption from peritoneal cavity into lymph nodes: particulate and oily inocula Exp. Mol. Pathol. 43 1985 124 134